“Serialization – Best Practices for Global Commercial Supply in an Evolving Market,” is the theme of the next free, specialist webinar from pharmaceutical outsourcing provider PCI Pharma Services (Thursday, June 29, 10-11am EDT / 3-4pm GMT).
The provider of life science webinars, Xtalks, will host the webinar, which is designed to enable professionals working in the field of serialization to understand established and developing serialization regulations that vary from country to country. The presentation will be delivered by Ian Parsonage, Senior Director, Global Serialization at PCI Pharma Services. It will offer an insight into meeting country-specific requirements based on his extensive experience in supplying commercial serialized medicines to domestic and emerging markets across the globe.
Parsonage says, “Serialization requirements are rapidly progressing and evolving in countries around the world. Evidence has shown drug counterfeiting is on the rise and significant regulatory deadlines are fast-approaching. The pharmaceutical supply chain is at a critical point to ensure patient safety. From drug manufacturers to distributors, all supply chain partners will need to make crucial decisions to upgrade their production lines in compliance with traceability deadlines.
PCI’s free learning event will enable participants to understand the following:
• The complexities of supplying commercial serialized products to domestic and emerging markets across the globe.
• The requirements for the fast-approaching regulatory deadlines in various countries.
• The key considerations when choosing an outsourcing partner for implementing a successful serialization strategy.
• Serialization best practices for global commercial supply in an evolving market.
In leading PCI’s Serialization strategy and implementation, Parsonage joined PCI Pharma Services in 2009, and has helped lead the organization in various IT and supply chain roles in both Europe and North America. Parsonage features over 25 years’ experience in the industry. In his current capacity, he works directly with pharmaceutical and biotech clients to implement their serialization and anti-counterfeiting strategies for global supply, and has responsibility for all Serialization activity in both the U.S. and U.K.